Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011;364: 797 805. 313. Grosskopf I, Rabinovitz M, Rosenfeld JB. Combination of furosemide and metolazone in the treatment of severe congestive heart failure. Isr J Med Sci 1986;22:787 90. 314. Channer KS, McLean KA, Lawson-Matthew P, et al. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J 1994;71:146 50. 315. Sigurd B, Olesen KH, Wennevold A. The supra-additive natriuretic effect addition of bendro umethiazide and bumetanide in congestive heart failure: permutation trial tests in patients in long-term treatment with bumetanide. Am Heart J 1975;89:163 70. 316. Rosenberg J, Gustafsson F, Galatius S, et al. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. Cardiovasc Drugs Ther 2005;19:301 6. 317. Giamouzis G, Butler J, Starling RC, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail 2010;16:922 30. 318. Elkayam U, Ng TM, Hatamizadeh P, et al. Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action. Circulation 2008;117:200 5. 319. Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultra ltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675 83. 320. Colucci WS, Elkayam U, Horton DP, et al., Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 2000;343:246 53. Errata in: N Engl J Med. 2000;343:1504 and N Engl J Med. 2000; 343:896. 321. Ciof G, Stefenelli C, Tarantini L, et al. 